Recuro Health is a technology company.
Recuro Health has raised $62.0M across 2 funding rounds.
Recuro Health has raised $62.0M in total across 2 funding rounds.
Recuro Health has raised $62.0M in total across 2 funding rounds.
Recuro Health's investors include ARCH Venture Partners, F-Prime Capital Partners, FTX Ventures, General Catalyst, Lux Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan McCabe, Karim Atiyeh, Scott Belsky.
Recuro Health is a technology company founded in 2021 that builds a virtual-first care delivery platform offering personalized, proactive virtual health services.[2][1][3] It serves employers, providers, and managed care organizations by solving access barriers in healthcare through integrated primary care, behavioral health, urgent care, supplemental benefits like pharmacy and care management, at-home lab testing, and genomics—all on a single, customizable, HITRUST-certified SaaS platform.[1][2][3][5] The platform shifts from reactive "sick care" to preventative care via health risk assessments, no utilization caps, multilingual support (over 100 languages), and potential savings of 25-30% on lost productivity, earning awards like Newsweek's World's Best Digital Health Companies and TIME's Top HealthTech.[1][3][4][7]
Recuro Health was founded in 2021 and is headquartered in Coppell, Texas.[2] While specific founders are not detailed in available sources, the company emerged amid the COVID-19 pandemic's surge in virtual care adoption, transforming marginal digital health use into widespread utilization.[3] Early traction came from developing a "Digital Medical Home" platform that integrates virtual services with proactive tools like genomic testing and health risk assessments, prioritizing prevention over reaction.[1][3][5] Pivotal moments include recognitions such as Newsweek's World's Best Digital Health Companies, TOP 10 in telehealth by Becker’s Hospital Review, and TIME's Top 25 HealthTech, solidifying its market position.[4][7]
Recuro rides the post-COVID telehealth boom, accelerating the shift to virtual-first, preventative care amid rising chronic diseases and demand for accessible, data-driven health solutions.[1][3][5] Timing aligns with AI advancements in clinical decision-making, RPM wearables, and genomic testing, enabling scalable platforms that integrate fragmented services for payers and employers.[5][6] Market forces like value-based care, cybersecurity needs, and hybrid virtual/brick-and-mortar models favor Recuro's holistic approach, influencing the ecosystem by promoting interoperable "Digital Medical Homes" that lower costs, boost engagement, and reduce readmissions.[1][3][5]
Recuro is poised to expand its AI-leveraged tools (e.g., personalized marketing and clinical predictions) and virtual offerings amid 2025's digital health focus on infrastructure, RPM, and genomics.[1][5][6] Trends like AI-driven outcomes, multilingual scalability, and employer-sponsored benefits will shape growth, potentially amplifying influence through partnerships and white-label expansions. As a leader in proactive telehealth, Recuro will likely deepen its role in making advanced care ubiquitous, building on its accessible platform to drive sustained health improvements and savings.
Recuro Health has raised $62.0M across 2 funding rounds. Most recently, it raised $47.0M Series B in April 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2023 | $47.0M Series B | ARCH Venture Partners, F-Prime Capital Partners, FTX Ventures, General Catalyst, Lux Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan McCabe, Karim Atiyeh, Scott Belsky | |
| Aug 1, 2021 | $15.0M Series A | ARCH Venture Partners, F-Prime Capital Partners, FTX Ventures, General Catalyst, Lux Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan McCabe, Karim Atiyeh, Scott Belsky |